BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korompoki E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, Kastritis E, Fotiou D, Stamatelopoulos K, Terpos E, Kotanidou A, Hagberg CA, Dimopoulos MA, Kontoyiannis DP. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J Infect 2021;83:1-16. [PMID: 33992686 DOI: 10.1016/j.jinf.2021.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Blann AD, Heitmar R. SARS-CoV-2 and COVID-19: A Narrative Review. Br J Biomed Sci 2022;79:10426. [DOI: 10.3389/bjbs.2022.10426] [Reference Citation Analysis]
2 Lekva T, Ueland T, Halvorsen B, Murphy SL, Dyrhol-Riise AM, Tveita A, Finbråten AK, Mathiessen A, Müller KE, Aaløkken TM, Skjønsberg OH, Lerum TV, Aukrust P, Dahl TB. Markers of cellular senescence is associated with persistent pulmonary pathology after COVID-19 infection. Infect Dis (Lond) 2022;:1-6. [PMID: 35984738 DOI: 10.1080/23744235.2022.2113135] [Reference Citation Analysis]
3 Azadvari M, Haghparast A, Nakhostin-Ansari A, Emami Razavi SZ, Hosseini M. Musculoskeletal symptoms in patients with long COVID: A cross-sectional study on Iranian patients. Heliyon 2022;8:e10148. [PMID: 35971463 DOI: 10.1016/j.heliyon.2022.e10148] [Reference Citation Analysis]
4 Wang Z, Le TT. The COVID-19 pandemic's effects on SMEs and travel agencies: The critical role of corporate social responsibility. Econ Anal Policy 2022. [PMID: 35919271 DOI: 10.1016/j.eap.2022.07.008] [Reference Citation Analysis]
5 Diniz FC, Hipkiss AR, Ferreira GC. The Potential Use of Carnosine in Diabetes and Other Afflictions Reported in Long COVID Patients. Front Neurosci 2022;16:898735. [DOI: 10.3389/fnins.2022.898735] [Reference Citation Analysis]
6 Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, Primus-de Jong C, Cleemput I, Van den Heede K. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 2022;54:1473-87. [PMID: 35594336 DOI: 10.1080/07853890.2022.2076901] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med 2022;28:911-23. [PMID: 35585196 DOI: 10.1038/s41591-022-01810-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
8 Anghelescu A, Onose G, Popescu C, Băilă M, Stoica S, Postoiu R, Brumă E, Petcu I, Ciobanu V, Munteanu C. Parkinson’s Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment. Biomedicines 2022;10:1000. [DOI: 10.3390/biomedicines10051000] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jin H, Lu L, Fan H. Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis. Int J Environ Res Public Health 2022;19:3742. [PMID: 35329428 DOI: 10.3390/ijerph19063742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Förster C, Colombo MG, Wetzel AJ, Martus P, Joos S. Persisting Symptoms After COVID-19. Dtsch Arztebl Int 2022;119:167-74. [PMID: 35236547 DOI: 10.3238/arztebl.m2022.0147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
11 Eroglu SE, Ademoglu E, Baslilar S, Aksel G, Eker A, Algın A, Islam MM, Ozdemir S. Can 1st and 6th month pulmonary function test follow-ups give an idea about the long-term respiratory effects of COVID-19 pneumonia? Rev Assoc Med Bras (1992) 2022;68:183-90. [PMID: 35239879 DOI: 10.1590/1806-9282.20210890] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Stefanou M, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, Rizos E, Boutati E, Grigoriadis N, Krogias C, Giannopoulos S, Tsiodras S, Gaga M, Tsivgoulis G. Neurological manifestations of long-COVID syndrome: a narrative review. Therapeutic Advances in Chronic Disease 2022;13:204062232210768. [DOI: 10.1177/20406223221076890] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
13 Domènech-montoliu S, Puig-barberà J, Pac-sa MR, Vidal-utrillas P, Latorre-poveda M, Del Rio-gonzález A, Ferrando-rubert S, Ferrer-abad G, Sánchez-urbano M, Aparisi-esteve L, Badenes-marques G, Cervera-ferrer B, Clerig-arnau U, Dols-bernad C, Fontal-carcel M, Gomez-lanas L, Jovani-sales D, León-domingo MC, Llopico-vilanova MD, Moros-blasco M, Notari-rodríguez C, Ruíz-puig R, Valls-lópez S, Arnedo-pena A. Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study. Epidemiologia 2022;3:49-67. [DOI: 10.3390/epidemiologia3010006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Pecetta S, Kratochvil S, Kato Y, Vadivelu K, Rappuoli R. Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines. Pharmacol Rev 2022;74:313-39. [PMID: 35101964 DOI: 10.1124/pharmrev.120.000285] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, Obeidat M, Obeidat Y, Gerberi D, Taha RM, Kashour Z, Kashour T, Berbari EF, Alkattan K, Tleyjeh IM. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.01.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 22.0] [Reference Citation Analysis]
16 Lee Y, Pagano S. Supportive Home Remedies for Orofacial Pain during the Coronavirus Disease 2019 Pandemic: Their Value and Limitations. International Journal of Dentistry 2022;2022:1-10. [DOI: 10.1155/2022/2005935] [Reference Citation Analysis]
17 Papadopoulos D, Ntanasis-stathopoulos I, Gavriatopoulou M, Evangelakou Z, Malandrakis P, Manola MS, Gianniou DD, Kastritis E, Trougakos IP, Dimopoulos MA, Karalis V, Terpos E. Predictive Factors for Neutralizing Antibody Levels Nine Months after Full Vaccination with BNT162b2: Results of a Machine Learning Analysis. Biomedicines 2022;10:204. [DOI: 10.3390/biomedicines10020204] [Reference Citation Analysis]
18 Xu B, Ma FQ, He C, Wu ZQ, Fan CY, Mao HR, Zhang JX, Yang M, Hu ZW. Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China. J Infect 2022:S0163-4453(21)00659-9. [PMID: 34986395 DOI: 10.1016/j.jinf.2021.12.040] [Reference Citation Analysis]
19 Johansson J, Levi R, Jakobsson M, Gunnarsson S, Samuelsson K. Multi-professional Neurorehabilitation after Covid-19 Infection Should Include Assessment of Visual Function. Archives of Rehabilitation Research and Clinical Translation 2022. [DOI: 10.1016/j.arrct.2022.100184] [Reference Citation Analysis]
20 Korompoki E, Gavriatopoulou M, Fotiou D, Ntanasis-Stathopoulos I, Dimopoulos MA, Terpos E. Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist. Am J Hematol 2022;97:119-28. [PMID: 34687462 DOI: 10.1002/ajh.26384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
21 Samartsev IN, Zhivolupov SA, Butakova JS, Parshin MS. [The open observational study of aceclofenac and vinpocetine effectiveness and tolerability in treatment of patients with chronic cerebrovascular disease after COVID-19 (AQUA study)]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:s1-8. [PMID: 34968019 DOI: 10.17116/jnevro2021121111s1] [Reference Citation Analysis]
22 Xu B, Ma FQ, He C, Wu ZQ, Fan CY, Mao HR, Zhang JX, Yang M, Hu ZW. Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China. J Infect 2021:S0163-4453(21)00642-3. [PMID: 34963637 DOI: 10.1016/j.jinf.2021.12.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Terpos E, Karalis V, Ntanasis-Stathopoulos I, Apostolakou F, Gumeni S, Gavriatopoulou M, Papadopoulos D, Malandrakis P, Papanagnou ED, Korompoki E, Kastritis E, Papassotiriou I, Trougakos IP, Dimopoulos MA. Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals. Hemasphere 2022;6:e677. [PMID: 34938959 DOI: 10.1097/HS9.0000000000000677] [Reference Citation Analysis]
24 Rabady S, Altenberger J, Brose M, Denk-Linnert DM, Fertl E, Götzinger F, de la Cruz Gomez Pellin M, Hofbaur B, Hoffmann K, Hoffmann-Dorninger R, Koczulla R, Lammel O, Lamprecht B, Löffler-Ragg J, Müller CA, Poggenburg S, Rittmannsberger H, Sator P, Strenger V, Vonbank K, Wancata J, Weber T, Weber J, Weiss G, Wendler M, Zwick RH. [Guideline S1: Long COVID: Diagnostics and treatment strategies]. Wien Klin Wochenschr 2021;133:237-78. [PMID: 34851455 DOI: 10.1007/s00508-021-01974-0] [Reference Citation Analysis]
25 Boglione L, Meli G, Poletti F, Rostagno R, Moglia R, Cantone M, Esposito M, Scianguetta C, Domenicale B, Di Pasquale F, Borrè S. Risk factors and incidence of Long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM 2021:hcab297. [PMID: 34850210 DOI: 10.1093/qjmed/hcab297] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
26 Gavriatopoulou M, Terpos E, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Fotiou D, Migkou M, Theodorakakou F, Eleutherakis-Papaiakovou E, Kanellias N, Kastritis E, Trougakos IP, Dimopoulos MA. Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study. Blood Adv 2021;5:4398-405. [PMID: 34529762 DOI: 10.1182/bloodadvances.2021005444] [Reference Citation Analysis]
27 France K, Glick M. Long COVID and oral health care considerations. J Am Dent Assoc 2021:S0002-8177(21)00517-1. [PMID: 34756590 DOI: 10.1016/j.adaj.2021.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Liao T, Meng D, Xiong L, Wu S, Yang L, Wang S, Zhou M, He X, Cao X, Xiong H, Fan Y, Xia J, Hu Y, Jin Y. Long-Term Effects of COVID-19 on Health Care Workers 1-Year Post-Discharge in Wuhan. Infect Dis Ther 2021. [PMID: 34687442 DOI: 10.1007/s40121-021-00553-0] [Reference Citation Analysis]
29 Weinberger B. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun Ageing 2021;18:38. [PMID: 34627326 DOI: 10.1186/s12979-021-00249-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
30 Terpos E, Gavriatopoulou M, Fotiou D, Giatra C, Asimakopoulos I, Dimou M, Sklirou AD, Ntanasis-Stathopoulos I, Darmani I, Briasoulis A, Kastritis E, Angelopoulou M, Baltadakis I, Panayiotidis P, Trougakos IP, Vassilakopoulos TP, Pagoni M, Dimopoulos MA. Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study. Cancers (Basel) 2021;13:4480. [PMID: 34503290 DOI: 10.3390/cancers13174480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
31 Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Fotiou D, Papanagnou ED, Migkou M, Theodorakakou F, Roussou M, Eleutherakis-Papaiakovou E, Kanellias N, Trougakos IP, Kastritis E, Dimopoulos MA. The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment. Blood Cancer J 2021;11:138. [PMID: 34341335 DOI: 10.1038/s41408-021-00530-3] [Cited by in F6Publishing: 43] [Reference Citation Analysis]
32 Terpos E, Trougakos IP, Karalis V, Ntanasis-Stathopoulos I, Gumeni S, Apostolakou F, Sklirou AD, Gavriatopoulou M, Skourti S, Kastritis E, Korompoki E, Papassotiriou I, Dimopoulos MA. Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers. Cells 2021;10:1942. [PMID: 34440710 DOI: 10.3390/cells10081942] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
33 Terpos E, Politou M, Ntanasis-Stathopoulos I, Karalis V, Merkouri E, Fotiou D, Gavriatopoulou M, Malandrakis P, Kastritis E, Trougakos IP, Dimopoulos MA. High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events. Vaccines (Basel) 2021;9:712. [PMID: 34358129 DOI: 10.3390/vaccines9070712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
34 Fernández-de-Las-Peñas C, Gómez-Mayordomo V, de-la-Llave-Rincón AI, Palacios-Ceña M, Rodríguez-Jiménez J, Florencio LL, Velasco-Arribas M, Fuensalida-Novo S, Cigarán-Méndez M, Ambite-Quesada S, Guijarro C, Cuadrado ML, Arias-Navalón JA, Ortega-Santiago R, Elvira-Martínez CM, Molina-Trigueros LJ, Torres-Macho J, Sebastián-Viana T, Canto-Diez MG, Hernández-Barrera V, Palacios-Ceña D. Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study. J Infect 2021:S0163-4453(21)00319-4. [PMID: 34192525 DOI: 10.1016/j.jinf.2021.06.022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]